Article Text

Download PDFPDF
Arthroscopic surgery for degenerative knee: Overused, ineffective, and potentially harmful
  1. Andy Carr
  1. Correspondence to Botnar Research Centre, Oxford University Institute of Musculoskeletal Sciences, NIHR Oxford Musculoskeletal Biomedical Research Unit, Oxford OX3 7LD, UK

Statistics from Altmetric.com

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

The most frequent indication for knee arthroscopy is degenerative joint disease in middle aged and older patients. Each year, more than 700 000 knee arthroscopies are done in the United States and 150 000 in the United Kingdom.1 Magnetic resonance imaging evidence of meniscal abnormality, osteophytes, cartilage damage, and bone marrow lesions is often present. All these imaging abnormalities are common in the general population and are often asymptomatic.2 The evidence base for arthroscopic surgery is known to be weak, and a pressing need exists for more high quality multicentre randomised controlled trials, systematic reviews, and meta-analyses to inform clinicians and improve care for patients.3 Researchers have already reported that trials of arthroscopic surgery find no benefit over control interventions ranging from exercises to placebo surgery.4

A linked paper by Thorlund and colleagues (doi:10.1136/bmj. h2747) adds substantially to the debate by systematically reviewing all the evidence on the benefits and harms of arthroscopic knee surgery for middle aged and older adults with knee pain and degenerative knee disease.5 The authors report that the small benefit seen after arthroscopic surgery of the knee …

View Full Text

Footnotes

  • Note This paper is republished from The BMJ 2015;350:h2983 doi: 10.1136/bmj.h2983 (Published 16 June 2015).

  • Competing interests AC is supported by the NIHR Oxford Biomedical Research Unit and has received research grants from NIHR and Arthritis Research UK.

  • Provenance Commissioned; not externally peer reviewed.